About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | GLORIA-AF Registry Program - Second and Third Phases

GLORIA-AF Registry Program - Second and Third Phases

NCT01468701·666 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Boehringer Ingelheim

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Age =\>18 years at enrollment
2. Male or female patient (or legally acceptable representative) willing and able to provide written informed consent
3. Patient newly diagnosed (\< 3 months prior to baseline visit) with non-valvular AF and at risk for stroke.

You may not be if

1. Presence of any mechanical heart valve, or valve disease that is expected to require valve replacement intervention;
2. Patients who have received more than 60 days of vitamin K antagonist (VKA) treatment in their lifetime;
3. AF with a generally reversible cause;

The record

StatusCompleted

PhaseNo phase

Taking part37,235

StartedNov 2011

UpdatedMar 29, 2021

Conditions

Stroke Atrial Fibrillation

Where666

University South Alabama Medical Center
Mobile, Alabama, United States
Black Warrior Research
Northport, Alabama, United States
Scottsboro Quick Care Clinic
Scottsboro, Alabama, United States